Biologic profiles meet clinical priorities: incorporating pseudopyloric, and spasmolytic-expressing metaplasia in the assessment of gastric atrophy
Crossref DOI link: https://doi.org/10.1007/s00428-020-02814-8
Published Online: 2020-05-11
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rugge, Massimo
Funding for this research was provided by:
Italian Health Ministry’s Research program (NET-2016-02363853)
Text and Data Mining valid from 2020-05-11
Version of Record valid from 2020-05-11
Article History
Received: 27 March 2020
Revised: 27 March 2020
Accepted: 5 April 2020
First Online: 11 May 2020